Clinical trial
BNCT to Treat Glioma That Has Progressed Following Radiotherapy
NCT00115440 · Boneca Corporation, Industry · Completed
Key facts
| NCT number | NCT00115440 |
|---|---|
| Title | BNCT to Treat Glioma That Has Progressed Following Radiotherapy |
| Official title | BPA-Mediated Boron Neutron Capture Therapy (BNCT) in the Treatment of Glioblastoma or Anaplastic Astrocytoma Progressing After Conventional External Beam Radiotherapy |
| Lead sponsor | Boneca Corporation, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma, Anaplastic Astrocytoma |
| Intervention type | Radiation |
| Interventions | Bononophenylalanine (BPA)-based BNCT |
| Enrollment | 22 |
| Start date | Mar 1, 2001 |
| Primary completion | Dec 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jun 23, 2005 |
| Last update posted | Jan 28, 2009 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: